Andrea Veronesi

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

Luca Gianni, Urania Dafni, Richard D. Gelber et al. · The Lancet Oncology · 2011 · 611 citations

Medicine, Oncology, Breast Oncology +13

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Diana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch et al. · Journal of Clinical Oncology · 2000 · 295 citations

Medicine, Oncology, Pharmacology +15

Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features

Maria Antonietta Pizzichetta, Renato Talamini, Ignazio Stanganelli et al. · British Journal of Dermatology · 2004 · 236 citations

Medicine, Dermatology, Oncology +17

Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding

Barbara Belletti, Jayant S. Vaidya, Sara D’Andrea et al. · Clinical Cancer Research · 2008 · 232 citations

Medicine, Oncology, Surgery +17

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Diana Crivellari, Olivia Pagani, Andrea Veronesi et al. · Annals of Oncology · 2001 · 151 citations · Full text

Medicine, Oncology, Pharmacology +14